BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17201235)

  • 1. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
    Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into Eosinophilic Otitis Media.
    Kanazawa H; Yoshida N; Iino Y
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal of a Treatment Strategy for Eosinophilic Otitis Media Based on Middle Ear Condition.
    Esu Y; Iino Y; Masuda M; Kanazawa H; Yoshida N
    Otol Neurotol; 2018 Sep; 39(8):e671-e678. PubMed ID: 30113562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y; Takahashi E; Ida S; Kikuchi S
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion.
    Tracy JM; Demain JG; Hoffman KM; Goetz DW
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):198-206. PubMed ID: 9494455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H; Yoshida N; Shinnabe A; Iino Y
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE; Kang YS; Cho Y; Park MK
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The analysis of the correlation of tympanic injection of triamcinolone acetonide and middle ear pressure after radiotherapy].
    Xie H; Sun W; Qin Weihong ; Que Y; Dai S; Zhen Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 28(22):1785-8. PubMed ID: 25752115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trial.
    Gluth MB; McDonald DR; Weaver AL; Bauch CD; Beatty CW; Orvidas LJ
    Arch Otolaryngol Head Neck Surg; 2011 May; 137(5):449-55. PubMed ID: 21576556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IgE in eosinophilic otitis media.
    Iino Y
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic otitis media and comorbid asthma.
    Seo Y; Nonaka M; Pawankar R
    Curr Opin Allergy Clin Immunol; 2020 Feb; 20(1):9-13. PubMed ID: 31524656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.